US Patent 7553826 Cytarabine monophosphate prodrugs
Patent 7553826 was granted and assigned to METABASIS THERAPEUTICS, INC. on June, 2009 by the United States Patent and Trademark Office.
All edits
Edits on 15 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 1 May, 2024
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Patent Citations Received
Edits on 17 Sep, 2023
Golden AI
Edits made to:
Infobox (+2 properties)
Infobox
Patent Inventor Names
Mark D. Erion0
Serge Boyer0
Edits on 15 Sep, 2023
Golden AI
Edits made to:
Article (+80 characters)
Article
Patent abstract
Compounds of Formula I, their preparation and uses are described:
Edits on 14 Jul, 2023
Golden AI
Edits made to:
Infobox (+1/-1 properties)
US Patent 07553826 Cytarabine monophosphate prodrugs US Patent 7553826 Cytarabine monophosphate prodrugs
Infobox
Patent Number
075538260
Patent Number
75538260
Edits on 22 May, 2023
Golden AI
Edits made to:
Infobox (-1 properties)
Infobox
Official Website
Edits on 27 Sep, 2022
Golden AI
Infobox
Is a
Current Assignee
Patent Jurisdiction
Patent Number
075538260
Date of Patent
June 30, 2009
0Patent Application Number
115823830
Date Filed
October 18, 2006
0Official Website
Patent Primary Examiner
Edits on 18 Jun, 2022
Golden AI
Edits made to:
Infobox (+1 properties)
Infobox
Website URL
Edits on 2 Dec, 2021
Golden AI
Edits made to:
Infobox (+8 properties)
US Patent 07553826 Cytarabine monophosphate prodrugs
Infobox
Is a
Current assignee
Patent jurisdiction
Patent number
07553826
Date of patent
June 30, 2009
Patent application number
11582383
Date Filed
October 18, 2006
Patent primary examiner
Find more entities like US Patent 7553826 Cytarabine monophosphate prodrugs
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.